Detalles de la búsqueda
1.
Weight-based mycophenolate mofetil dosing predicts acute GVHD and relapse after allogeneic hematopoietic cell transplantation.
Eur J Haematol
; 106(2): 205-212, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33084139
2.
Comparison of continuous versus intermittent infusion cyclosporine and impact on transplant related outcomes in allogeneic transplant recipients.
J Oncol Pharm Pract
; 27(8): 1835-1841, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33138698
3.
Use of Potentially Inappropriate Medications in Older Allogeneic Hematopoietic Cell Transplantation Recipients.
Biol Blood Marrow Transplant
; 26(12): 2329-2334, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32919078
4.
Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(3): 480-487, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30423481
5.
Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(12): e20-e25, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30053647
6.
Adjusting Cyclophosphamide Dose in Obese Patients with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 22(3): 571-4, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26497907
7.
Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis for Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.
Biol Blood Marrow Transplant
; 22(11): 2025-2030, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27519278
8.
Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood Transplantation.
Biol Blood Marrow Transplant
; 21(5): 926-33, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25655791
9.
Impact of melphalan day -1 vs day -2 on outcomes after autologous stem cell transplant for multiple myeloma.
Front Immunol
; 15: 1310752, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38504993
10.
Impact of CDC warning on co-prescribing of opioids and benzodiazepines in older allogeneic hematopoietic cell transplant recipients.
Bone Marrow Transplant
; 57(7): 1079-1085, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35461360
11.
Effects of cyclophosphamide related genetic variants on clinical outcomes of adult hematopoietic cell transplant patients.
Cancer Chemother Pharmacol
; 89(4): 543-549, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35083501
12.
Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.
Biol Blood Marrow Transplant
; 22(8): 1348-1356, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27131865
13.
CD33-Targeted Therapies: Beating the Disease or Beaten to Death?
J Clin Pharmacol
; 61(1): 7-17, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32875599
14.
Effect of Keratinocyte Growth Factor on Hospital Readmission and Regimen-Related Toxicities after Autologous Hematopoietic Cell Transplantation for Lymphoma.
Transplant Cell Ther
; 27(2): 179.e1-179.e4, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33830033
15.
Higher Fludarabine and Cyclophosphamide Exposures Lead to Worse Outcomes in Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Adult Hematologic Malignancy.
Transplant Cell Ther
; 27(9): 773.e1-773.e8, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34044184
16.
Prophylactic Foscarnet for Human Herpesvirus 6: Effect on Hematopoietic Engraftment after Reduced-Intensity Conditioning Umbilical Cord Blood Transplantation.
Transplant Cell Ther
; 27(1): 84.e1-84.e5, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33053448
17.
High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group.
Blood Cancer J
; 11(5): 96, 2021 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34006823
18.
Highly variable mycophenolate mofetil bioavailability following nonmyeloablative hematopoietic cell transplantation.
J Clin Pharmacol
; 47(1): 6-12, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17192496
19.
Suppressor function of umbilical cord blood-derived CD4+CD25+ T-regulatory cells exposed to graft-versus-host disease drugs.
Transplantation
; 82(1): 23-9, 2006 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16861937
20.
Personalized fludarabine dosing to reduce nonrelapse mortality in hematopoietic stem-cell transplant recipients receiving reduced intensity conditioning.
Transl Res
; 175: 103-115.e4, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27094990